ITI-1771

N/A

Report date: 2026/05/12 15:11:30

Base Information

Drug NameITI-1771

Drug Alias NameITI-1771

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > self-amplifying RNA vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsColorectal NeoplasmsTriple Negative Breast NeoplasmsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesImmunomic Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesImmunomic Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsColorectal NeoplasmsTriple Negative Breast NeoplasmsGlioblastoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A